HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings.

Presented at the College on Problems of Drug Dependence annual meeting, June 17-22, 2006.

Robert E. Booth, PhD (University of Colorado, RM Node).

This presentation describes CTN protocol 0017, "HIV and HCV Interventions in Drug Treatment Settings." This study tests two strategies to reduce the risk of contracting HIV or HCV by reducing risk behaviors in patients undergoing drug detoxification. The first includes pretest counseling, testing, posttest counseling, and the provision of HIV/HCV results. The second strategy, called therapeutic alliance, provides clients with information to guide them through the process of role induction and aims to facilitate transition to continuing care for drug treatment. The presentation describes the Nodes and CTPs involved in CTN-0017, as well as its objectives, methods, and progress of the study so far. (Presentation, PowerPoint slides, English, 2006)

Keywords: HIV/AIDS | Hepatitis C | Injection drug use | Sexual risk behavior | Sexually transmitted diseases | Therapeutic alliance | College on Problems of Drug Dependence (CPDD) annual meeting 2006

Document No: 101

Submitted by Robert E. Booth, PhD, Lead Investigator (6/8/2005).